GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.14 $2.79 Thursday, 18th Apr 2024 FGEN stock ended at $1.17. This is 7.87% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 13.16% from a day low at $1.14 to a day high of $1.29.
90 days $0.760 $2.93
52 weeks $0.335 $20.52

Historical FibroGen prices

Date Open High Low Close Volume
2020-10-23 $45.93 $46.36 $42.42 $42.60 1 078 394
2020-10-22 $45.39 $47.80 $45.39 $45.61 708 557
2020-10-21 $45.31 $46.42 $44.91 $45.10 406 297
2020-10-20 $46.47 $46.97 $45.21 $45.49 421 684
2020-10-19 $46.40 $46.78 $45.46 $45.76 524 987
2020-10-16 $48.59 $48.59 $45.91 $46.12 724 668
2020-10-15 $46.02 $47.06 $45.33 $46.39 403 222
2020-10-14 $49.27 $49.38 $46.86 $46.88 617 056
2020-10-13 $48.19 $49.41 $47.82 $48.87 426 111
2020-10-12 $49.21 $49.70 $48.52 $48.97 435 179
2020-10-09 $46.87 $49.23 $45.66 $48.82 676 802
2020-10-08 $45.00 $46.73 $44.62 $46.62 533 596
2020-10-07 $43.00 $44.81 $42.89 $44.58 602 344
2020-10-06 $44.07 $44.79 $42.55 $42.63 393 992
2020-10-05 $41.90 $44.30 $41.71 $43.90 600 480
2020-10-02 $40.46 $41.67 $40.28 $41.36 999 512
2020-10-01 $41.31 $41.63 $40.25 $40.97 953 190
2020-09-30 $41.61 $41.80 $40.94 $41.12 822 525
2020-09-29 $43.02 $43.07 $41.49 $41.62 672 035
2020-09-28 $42.58 $43.80 $42.37 $43.01 603 402
2020-09-25 $42.61 $43.34 $41.72 $42.27 769 035
2020-09-24 $44.00 $44.20 $42.21 $42.79 435 635
2020-09-23 $43.97 $44.52 $43.54 $44.00 614 349
2020-09-22 $43.65 $43.88 $41.49 $43.84 699 049
2020-09-21 $43.94 $44.20 $42.88 $43.49 939 639
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT